Gen-probe Incorporated
UnclaimedIn-Vitro Diagnostic Substance ManufacturingMarlborough, MA
Founded
1984
Primary NAICS
325413
CAGE code
0BDV3
Federal awards
$32.3M
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- In-Vitro Diagnostic Substance Manufacturing325413
Capabilities
Testing Laboratories and ServicesFamily Planning CentersAll Other Outpatient Care CentersMedical LaboratoriesPsychiatric and Substance Abuse HospitalsSpecialty (except Psychiatric and Substance Abuse) HospitalsOther Individual and Family Services
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Defense | $25,220 | 2 |
| 2025 | Department of Defense | $129,435 | 5 |
| 2025 | Department of Veterans Affairs | $0 | 1 |
| 2025 | Department of Health and Human Services | $0 | 1 |
| 2024 | Department of Defense | $1,070,360 | 11 |
| 2024 | Department of Veterans Affairs | -$1,775,315 | 2 |
| 2023 | Department of Defense | $14,457,255 | 53 |
| 2023 | Department of Veterans Affairs | $1,510,238 | 10 |
| 2022 | Department of Defense | $12,028,160 | 121 |
| 2022 | Department of Veterans Affairs | $4,743,958 | 10 |
| 2022 | Department of Health and Human Services | $70,000 | 1 |